Literature DB >> 30128080

Tariquidar-Related Chalcones and Ketones as ABCG2 Modulators.

Diana Peña-Solórzano1,2, Matthias Scholler2, Günther Bernhardt2, Armin Buschauer2, Burkhard König2, Cristian Ochoa-Puentes1.   

Abstract

ABC transporters, including ABCG2, play a vital role in defending the human body against the vast range of xenobiotics. Even though this is beneficial for human health, these protein transporters have been implicated in the emerging resistance of cancer cells to a variety of structurally and functionally diverse anticancer drugs. In order to investigate their role in resistance, potent and selective ABCG2 modulators have been described in the literature. A leading class of modulators are the tariquidar analogues; however, their susceptibility to hydrolysis limits their applicable use. To overcome this, we synthesized a novel series of chalcone- and ketone-based compounds inspired by reported tariquidar analogues. Compounds were characterized and evaluated for their ABCG2 modulatory activity and ABC transporter selectivity. When compared to transporters ABCB1 and ABCC1, the chalcone-based compounds exhibited selectivity for ABCG2, while the ketone-based compounds showed only a slight preference for ABCG2. From the former series, chalcone 16d (UR-DP48) displayed similar activity to the reference fumitremorgin C, both producing comparable maximal effects. The compound exhibited marked antiproliferative activity, while cytotoxicity was less pronounced for the most active compound 17f from the ketone series. Chalcone-containing tariquidar analogues are promising modulators to aid in functional investigations of ABCG2 transporters.

Entities:  

Year:  2018        PMID: 30128080      PMCID: PMC6088357          DOI: 10.1021/acsmedchemlett.8b00289

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  28 in total

1.  Guidelines for accurate EC50/IC50 estimation.

Authors:  J L Sebaugh
Journal:  Pharm Stat       Date:  2011 Mar-Apr       Impact factor: 1.894

2.  Flavonoid derivatives as selective ABCC1 modulators: Synthesis and functional characterization.

Authors:  José Esteban Obreque-Balboa; Qiu Sun; Günther Bernhardt; Burkhard König; Armin Buschauer
Journal:  Eur J Med Chem       Date:  2015-12-13       Impact factor: 6.514

3.  Standardized kinetic microassay to quantify differential chemosensitivity on the basis of proliferative activity.

Authors:  G Bernhardt; H Reile; H Birnböck; T Spruss; H Schönenberger
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

Review 4.  Structure, function, expression, genomic organization, and single nucleotide polymorphisms of human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) efflux transporters.

Authors:  Supratim Choudhuri; Curtis D Klaassen
Journal:  Int J Toxicol       Date:  2006 Jul-Aug       Impact factor: 2.032

5.  Solid phase synthesis of tariquidar-related modulators of ABC transporters preferring breast cancer resistance protein (ABCG2).

Authors:  Cristian Ochoa Puentes; Peter Höcherl; Matthias Kühnle; Stefanie Bauer; Kira Bürger; Günther Bernhardt; Armin Buschauer; Burkhard König
Journal:  Bioorg Med Chem Lett       Date:  2011-04-28       Impact factor: 2.823

6.  Structural basis of small-molecule inhibition of human multidrug transporter ABCG2.

Authors:  Scott M Jackson; Ioannis Manolaridis; Julia Kowal; Melanie Zechner; Nicholas M I Taylor; Manuel Bause; Stefanie Bauer; Ruben Bartholomaeus; Guenther Bernhardt; Burkhard Koenig; Armin Buschauer; Henning Stahlberg; Karl-Heinz Altmann; Kaspar P Locher
Journal:  Nat Struct Mol Biol       Date:  2018-04-02       Impact factor: 15.369

Review 7.  Anticancer multidrug resistance mediated by MRP1: recent advances in the discovery of reversal agents.

Authors:  Ahcène Boumendjel; Hélène Baubichon-Cortay; Doriane Trompier; Thomas Perrotton; Attilio Di Pietro
Journal:  Med Res Rev       Date:  2005-07       Impact factor: 12.944

8.  Benzanilide-Biphenyl Replacement: A Bioisosteric Approach to Quinoline Carboxamide-Type ABCG2 Modulators.

Authors:  Cristian Ochoa-Puentes; Stefanie Bauer; Matthias Kühnle; Günther Bernhardt; Armin Buschauer; Burkhard König
Journal:  ACS Med Chem Lett       Date:  2013-03-04       Impact factor: 4.345

9.  New structure-activity relationships of chalcone inhibitors of breast cancer resistance protein: polyspecificity toward inhibition and critical substitutions against cytotoxicity.

Authors:  Luciana Pereira Rangel; Evelyn Winter; Charlotte Gauthier; Raphaël Terreux; Louise D Chiaradia-Delatorre; Alessandra Mascarello; Ricardo J Nunes; Rosendo A Yunes; Tania B Creczynski-Pasa; Sira Macalou; Doriane Lorendeau; Hélène Baubichon-Cortay; Antonio Ferreira-Pereira; Attilio Di Pietro
Journal:  Drug Des Devel Ther       Date:  2013-09-30       Impact factor: 4.162

Review 10.  The multidrug transporter ABCG2: still more questions than answers.

Authors:  Aaron J Horsey; Megan H Cox; Sunehera Sarwat; Ian D Kerr
Journal:  Biochem Soc Trans       Date:  2016-06-15       Impact factor: 5.407

View more
  2 in total

Review 1.  Recent advances in the search of BCRP- and dual P-gp/BCRP-based multidrug resistance modulators.

Authors:  Silvia Dei; Laura Braconi; Maria Novella Romanelli; Elisabetta Teodori
Journal:  Cancer Drug Resist       Date:  2019-09-19

Review 2.  Two Important Anticancer Mechanisms of Natural and Synthetic Chalcones.

Authors:  Teodora Constantinescu; Alin Grig Mihis
Journal:  Int J Mol Sci       Date:  2022-09-30       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.